At the American Society of Clinical Oncology meeting, investors got a closer look at the drugs biotechnology companies are testing. Join Adam Feuerstein,
biotechnology reporter, to hear the inside scoop on the latest research and outlook for the industry. And with blockbusters such as "Spider-Man" raking in bucks at the box office, Happy Hour sat down with David Miller, analyst at Sanders Morris Harris, to handicap the summer movie season. Also, a toast to the FCC and the weekly Markets Roundtable.